Hop Claude Huriez Chu Lille
Lille, 59037, France
NCT Number: NCT04371692
The objective of this study is to determine the prevalence of SARS-Cov2 infection among health care workers exposed of Lille University Hospital, to describe its evolution during the epidemic taking into account the influence of occupational and environmental exposure determinants.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lille, 59037, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Every weeks during 2 months, clinical and occupational questionnaire are performed among a cohort of HCW exposed to covid occupational exposure
Other names: a specifically designed self-administered questionnaire
Every weeks during 2 month, SARS-Cov2 RT-PCR, serological testing are performed among a cohort of HCW exposed to covid occupational exposure
Time frame: at 2 months
Time frame: once week during 2 months
Time frame: once week during 2 months
Time frame: once week during 2 months
Time frame: once week during 2 months
Time frame: once week during 2 months
University Hospital, Lille
Other
Prevalence of SARS-Cov2 Infection Among HCW in Lille University Hospital
Acronym: EXPOCOVIA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04353609
Autoimmune Diseases, COVID-19
Lille, France
View Trial DetailsNCT04356495
Corona Virus Infection, Coronaviridae Infections
Bordeaux, France
View Trial DetailsNCT04378842
COVID-19, Coronaviridae Infections
Amiens, France
View Trial DetailsNCT04393974
Cancer, Neoplasms
Brussels, Belgium
View Trial Details